Regulus Alnylam

Related by string. * : Regulus Therapeutics Inc. . Regulus Therapeutics . Regulus Therapeutics joint venture . Regulus Therapeutics LLC . Regulus / : comprise Alnylam RNAi . Alnylam dependence . Alnylam maintains . formed Alnylam Biotherapeutics . Alnylam Pharmaceuticals ALNY . Alnylam Pharmaceuticals NASDAQ ALNY . Alnylam Pharmaceuticals Nasdaq ALNY . Alnylam RNAi therapeutics * *

Related by context. Frequent words. (Click for all words.) 62 www.isispharm.com 58 www.combinatorx.com 58 www.exelixis.com 57 iCo Therapeutics 56 http:/www.exelixis.com 56 R sorafenib tablets 55 www.vical.com 55 www.myriad.com 54 Hybridon 54 Isis Pharmaceuticals 54 www.allos.com 54 suchforward looking 54 risks anduncertainties 54 www.tekmirapharm.com 54 Mipomersen 54 Elixir Pharmaceuticals 54 prostones 53 Gilead assumes 53 Ardea Biosciences 53 Regulus Therapeutics LLC 53 theforward looking 53 www.pdl.com 53 deforolimus 53 Regulus Therapeutics 52 Ceregene 52 www.emergentbiosolutions.com 52 Sunesis Pharmaceuticals 52 Hana Biosciences 52 OR SIMILAR STATEMENTS ARE 52 www.syntapharma.com 52 Paris EURONEXT SAN 51 www.norsat.com 51 Statements Statements 51 Antisense 51 Opexa Therapeutics 51 Qualitative Disclosures About 51 Nanobac Pharmaceuticals Inc. 51 BioMarin Pharmaceutical 51 should consult Cytokinetics 51 Entereg R 51 RXi Pharmaceutical Corporation 50 ISIS # 50 http:/www.pery.com 50 teplizumab 50 Factors Affecting Forward Looking 50 visit www.oncolyticsbiotech.com 50 * Potentially libelous 50 Myrexis 50 Cobalamin 50 Statements Certain 50 Resverlogix Corp. 50 PLAVIX R 50 transportation storage terminalling 50 VIRxSYS 50 Ceragenix 50 forward lookingstatements 50 www.celgene.com 50 Preclinical Development 50 Nasdaq ISIS 50 APD# 49 theSecurities 49 PharmaFrontiers 49 http:/www.idg.com 49 Archemix Corp. 49 FavId 49 www.powersecure.com 49 Altus Pharmaceuticals 49 FoldRx 49 SANCTURA R 49 Oncolytics please 49 Idera Pharmaceuticals 49 Nortel strategic alliances 49 Phenomix 49 forward.looking statements 49 ADVISORY Certain information 49 Metabasis Therapeutics Inc. 49 www.citigroup.com 49 Gastrointestinal Cancers Symposium 49 www.genzyme.com 49 Full Prescribing Information 49 www.ipsen.com 49 TargeGen 48 www.phaseforward.com 48 Merrimack Pharmaceuticals 48 FINANCIAL CONDITION AND 48 Bioenvision compounds under 48 intents beliefs 48 acquisitions mergers dispositions 48 autoimmune indications 48 mysunshinecoast.com.au may 48 www.thqwireless.com 48 Assumptions relating 48 www.ses.com 48 Sangamo BioSciences 48 Protox 48 Stockholders Approve Merger 48 yet determinable 48 CoMentis 48 reflect Sentry Select 48 differmaterially 48 Ambrx

Back to home page